Xenetic Biosciences, Inc. (XBIO): Shareholders' Equity
$7.40M
As of 2025-12-31
$6.07M
As of 2026-06-30
-18.5%
3-year compound annual growth
-9.5%
5-year compound annual growth
+1.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.40M | +23.1% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $6.01M | -38.7% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $9.80M | -28.2% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $13.65M | -25.8% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $18.39M | +50.6% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $12.22M | -29.0% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $17.21M | +73.6% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $9.91M | -30.7% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $14.30M | -11.6% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $16.17M | +144.7% | 2018-03-30, Balance as of period end |
| 2015-12-31 | $6.61M | -36.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $10.48M | -16.9% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $12.62M | n/a | 2015-07-20, Balance as of period end |
| 2013-08-31 | -$182.1K | n/a | 2013-11-27, Balance as of period end |
| 2012-12-31 | $20.78M | n/a | 2015-07-20, Balance as of period end |
| 2012-08-31 | -$92.9K | n/a | 2013-11-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $7.40M | +23.1% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $339.77M | -27.7% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$126.24M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.80M | -9.5% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.83M | -24.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $22.74M | +193.5% |
Compare XBIO, TXMD, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗